This week on the podcast we have the CEO and Founder of A28 Therapeutics, Dr. Stanley T. Lewis.
A28 Therapeutics is a clinical-stage biopharmaceutical company focused on a new and very unique platform to treat multiple types of cancer.
In our discussion, Dr. Lewis tells us about the challenges of launching a company and the new skill sets he's had to develop along the way.
Click below to listen to the full episode.
Comments